Tubular maximum phosphate reabsorption capacity in living kidney donors is independently associated with one-year recipient GFR.

The donor glomerular filtration rate (GFR) measured before kidney donation is a strong determinant of recipient graft outcome. No tubular function markers have been identified that can similarly be used in donors to predict recipient outcomes. In the present study we investigated whether the pre-donation tubular maximum reabsorption capacity of phosphate (TmP-GFR), which may be considered a functional tubular marker in healthy kidney donors, is associated with recipient GFR at 1 yr after transplantation, a key determinant of long-term outcome. We calculated the pre-donation TmP-GFR from serum and 24-h urine phosphate and creatinine levels in 165 kidney donors, and recipient 125I-iothalamate GFR and eGFR (CKD-EPI) at 12 mo after transplantation. Kidney donors were 51 ± 10 yr old, 47% were men, and mean GFR was 118 ± 26 ml/min. The donor TmP-GFR was associated with recipient GFR 12 mo after transplantation (GFR 6.0 ml/min lower per 1 mg/dl decrement of TmP-GFR), which persisted after multivariable adjustment for donor age, sex, pre-donation GFR, and blood pressure and other potential confounders. Results were highly similar when eGFR at 12 mo was taken as the outcome. Tubular damage markers kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin were low and not associated with recipient GFR. A lower donor TmP-GFR before donation, which may be considered to represent a functional measure of tubular phosphate reabsorption capacity, is independently associated with a lower recipient GFR 1 yr after transplantation. These data are the first to link donor tubular phosphate reabsorption with recipient GFR post-transplantation.

[1]  V. Vallon Tubular Transport in Acute Kidney Injury: Relevance for Diagnosis, Prognosis and Intervention , 2016, Nephron.

[2]  Eva Dizin,et al.  Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling. , 2015, Journal of the American Society of Nephrology : JASN.

[3]  Amit X Garg,et al.  Living kidney donation: outcomes, ethics, and uncertainty , 2015, The Lancet.

[4]  F. Emma,et al.  Early effect of NTBC on renal tubular dysfunction in hereditary tyrosinemia type 1. , 2014, Molecular genetics and metabolism.

[5]  M. Mourad,et al.  Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation? , 2014, Clinical biochemistry.

[6]  F. Dekker,et al.  Long-term risks for kidney donors. , 2014, Kidney international.

[7]  G. Navis,et al.  Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[8]  J. Qiu,et al.  Donor factors predictive for poor outcomes of living donor kidney transplantation. , 2013, Transplantation proceedings.

[9]  T. Larson,et al.  Urine High and Low Molecular Weight Proteins One‐Year Post‐Kidney Transplant: Relationship to Histology and Graft Survival , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  Chul-woo Yang,et al.  Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis , 2013, BMC Nephrology.

[11]  C. Ronco,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences , 2012, Clinical chemistry and laboratory medicine.

[12]  H. Jüppner,et al.  Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23? , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  L. Tavazzi,et al.  Clinical outcome of renal tubular damage in chronic heart failure. , 2011, European heart journal.

[14]  Youhua Liu Cellular and molecular mechanisms of renal fibrosis , 2011, Nature Reviews Nephrology.

[15]  M. Mack,et al.  Kidney injury molecule‐1 and N‐acetyl‐ß‐d‐glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome , 2011, European journal of heart failure.

[16]  Huiliang Xie,et al.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. , 2011, Kidney international.

[17]  A. Molinolo,et al.  Tumor-induced osteomalacia. , 2011, Endocrine-related cancer.

[18]  F. Cosio,et al.  Living Donor Age and Kidney Transplant Outcomes , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  G. Navis,et al.  Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  M. Wolf,et al.  Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. , 2011, Journal of the American Society of Nephrology : JASN.

[21]  S. Bakker,et al.  Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes , 2011, Diabetes Care.

[22]  H. Jüppner Phosphate and FGF-23 , 2011, Kidney international. Supplement.

[23]  L. Stevens,et al.  Renal function equations before and after living kidney donation: a within-individual comparison of performance at different levels of renal function. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[24]  G. Navis,et al.  Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate , 2010, Heart.

[25]  N. Câmara,et al.  Functional and morphologic evaluation of kidney proximal tubuli and correlation with renal allograft prognosis , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[26]  P. Lips,et al.  Determination of fibroblast growth factor 23 , 2009, Annals of clinical biochemistry.

[27]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[28]  S. Ravera,et al.  The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi. , 2009, American journal of physiology. Renal physiology.

[29]  M. Stegall,et al.  Identifying Specific Causes of Kidney Allograft Loss , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  R. Gans,et al.  High Urinary Excretion of Kidney Injury Molecule-1 Is an Independent Predictor of Graft Loss in Renal Transplant Recipients , 2007, Transplantation.

[31]  F. Kronenberg,et al.  Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. , 2007, Journal of the American Society of Nephrology : JASN.

[32]  J. Chapman,et al.  Chronic Allograft Nephropathy: Current Concepts and Future Directions , 2006, Transplantation.

[33]  D. Rubinger,et al.  Regulation of the Renal Sodium-Dependent Phosphate Cotransporter NaPi2 (Npt2) in Acute Renal Failure due to Ischemia and Reperfusion , 2005, Nephron Physiology.

[34]  Christopher P. Johnson,et al.  Post-transplant renal function in the first year predicts long-term kidney transplant survival. , 2002, Kidney international.

[35]  B. Kasiske,et al.  A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  R. Béliveau,et al.  Effect of ischemia-reperfusion on the renal brush-border membrane sodium-dependent phosphate cotransporter NaPi-2. , 2001, Canadian journal of physiology and pharmacology.

[37]  N. Gretz,et al.  Altered expression of type II sodium/phosphate cotransporter in polycystic kidney disease. , 2000, Journal of the American Society of Nephrology : JASN.

[38]  J. Han,et al.  Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure. , 2000, American journal of physiology. Renal physiology.

[39]  R. B. Payne,et al.  Calculation of renal tubular reabsorption of phosphate: the algorithm performs better than the nomogram , 2000, Annals of clinical biochemistry.

[40]  R. Wolfe,et al.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. , 1999, The New England journal of medicine.

[41]  B. Kaissling,et al.  Parathyroid hormone and dietary phosphate provoke a lysosomal routing of the proximal tubular Na/Pi-cotransporter type II. , 1998, Kidney international.

[42]  R. B. Payne,et al.  Renal Tubular Reabsorption of Phosphate (TmP/GFR): Indications and Interpretation , 1998, Annals of clinical biochemistry.

[43]  A. Donker,et al.  Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. , 1996, Journal of the American Society of Nephrology : JASN.

[44]  S Takemoto,et al.  High survival rates of kidney transplants from spousal and living unrelated donors. , 1995, The New England journal of medicine.

[45]  W. Cates Age, Renal Tubular Phosphate Reabsorption, and Serum Phosphate Levels in Adults , 2008 .